25 May 2016 in Proceedings of the National Academy of Sciences
Significance: Characterizing the microstructure of an organ noninvasively using molecular diffusion measurements represents a major challenge in medical imaging and life science. In this work, we propose concepts in diffusion magnetic resonance to noninvasively extract morphological properties of brain cells that are out of reach of existing neuroimaging techniques, such as diffusion-weighted MRI. We show how long-range morphology of neurons and astrocytes can affect the diffusion of cell-specific metabolites at ultra-long diffusion times and that adequate modeling strategy seems to allow extracting morphological parameters such as astrocytic and neuronal process length and complexity, opening the way to noninvasive histology of the brain. We believe that the concepts and methods introduced here may represent a significant breakthrough in neuroimaging and neurosciences.
1 October 2016 in NeuroImage
MSMaria-Angeles Carrillo-De Sauvage
Maria-Angeles Carrillo-De Sauvage
+3
Huntington's disease (HD) is an inherited neurodegenerative disease characterized by motor, cognitive and psychiatric symptoms. Atrophy of the striatum has been proposed for several years as a biomarker to assess disease progression in HD gene carriers. However, it does not provide any information about the biological mechanisms linked to HD pathogenesis. Changes in brain metabolites have been also consistently seen in HD patients and animal models using Magnetic Resonance Spectroscopy (MRS), but metabolite measurements are generally limited to a single voxel. In this study, we used Chemical Exchange Saturation Transfer imaging of glutamate (gluCEST) in order to map glutamate distribution in the brain of a knock-in mouse model (Ki140CAG) with a precise anatomical resolution. We demonstrated that both heterozygous and homozygous mice with pathological CAG repeat expansion in gene encoding huntingtin exhibited an atrophy of the striatum and a significant alteration of their metabolic profile in the striatum as compared to wild type littermate controls. The striatal decrease was then confirmed by gluCEST imaging. Surprisingly, CEST imaging also revealed that the corpus callosum was the most affected structure in both genotype groups, suggesting that this structure could be highly vulnerable in HD. We evaluated for the first time gluCEST imaging as a potential biomarker of HD and demonstrated its potential for characterizing metabolic defects in neurodegenerative diseases in specific regions.
1 August 2012 in Biomaterials
31 March 2009 in NMR in Biomedicine
7 November 2016 in Magnetic Resonance in Medicine